SELLAS Life Sciences Income Statement (2011-2024) | SLS

Income Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Revenue & cost
Revenue 0.00B0.00B0.01B0.00B0.00B
Cost of Revenue 0.00B0.00B0.00B
Gross Profit 0.00B0.01B0.00B0.00B
Operating items
Research & Development 0.00B0.05B0.00B0.03B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.01B
Selling, General & Administrative 0.00B0.04B0.00B0.05B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Operating Expenses -0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.01B-0.00B0.00B0.00B0.00B
Operating Expenses 0.00B0.09B0.00B0.07B0.01B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Operating Income -0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
EBIT -0.01B-0.08B-0.02B-0.07B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Non-operating items
Interest & Investment Income 0.00B-0.00B0.00B0.00B
Other Non Operating Income 0.01B-0.02B-0.00B-0.01B
Non Operating Income 0.01B-0.02B-0.00B-0.01B0.00B0.00B0.00B0.00B0.00B0.00B
Net income details
EBT -0.01B-0.08B-0.02B-0.07B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Tax Provisions -0.00B-0.00B
Profit After Tax -0.07B-0.08B-0.02B-0.11B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Income from Continuing Operations -0.01B-0.08B-0.02B-0.07B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Consolidated Net Income -0.01B-0.08B-0.00B-0.04B-0.04B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Income towards Parent Company -0.01B-0.08B-0.00B-0.04B-0.04B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Preferred Dividend Payments 0.00B
Net Income towards Common Stockholders -0.01B-0.08B-0.00B-0.04B-0.04B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Additional items
EPS (Basic) -0.26-2.13-0.49-0.65-0.49-0.66-0.66-0.53-0.47-0.16-0.30-0.45-0.42-1.05-0.41-0.34-0.43-0.48-0.32-0.33-0.29
EPS (Weighted Average and Diluted) -0.26-0.66-0.53-0.47-0.16-0.30-0.45-0.42-1.05-0.41-0.34-0.43-0.48-0.32-0.33-0.29
Shares Outstanding (Weighted Average) 0.02B0.04B41.97B0.04B0.05B0.07B67.27B0.06B0.08B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.03B0.04B0.06B0.07B
Shares Outstanding (Diluted Average) 0.02B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.03B0.04B0.06B0.07B
EBITDA -0.01B-0.08B-0.02B-0.07B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Tax Rate 1.45%22.91%